Close Menu

NEW YORK (360Dx) – Microbiology firm BiosparQ is developing a MALDI-based system that can identify bacterial infections directly from patient samples without the need for culturing.

The Leiden, Netherlands-based company is currently evaluating the technology's usefulness for assessing urinary tract infections with researchers at Amsterdam University Hospital and aims to launch a CE-IVD-marked instrument for UTI detection in 2021, said René Parchen, the company's chief technology officer.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.